Literature DB >> 577337

Stimulation of peripheral T3 formation by oral but not by intravenous glucose administration in fasted subjects.

U Westgren, B Ahrén, A Burger, A Melander.   

Abstract

Fasting is known to promote a shift in the conversion of thyroxine (T4), more being deiodinated to an inactive form, reverse triiodothyronine (rT3), and less to active triiodothyronine (T3). The mechanism behind this change is not known, but it has recently been demonstrated that the proportion of dietary carbohydrates influences the serum concentration of T3 and rT3. Therefore, it is possible that the deiodination of T4 is subordinated to gastroenterohepatic regulation. To explore this possibility, we administrated glucose by the oral or the intravenous route to volunteers, who had been fasted for 48 h. It was found that glucose normalized the low fasting T3 concentrations only after oral administration. This supports the assumption that some gastro enterohepatic factor participates in the regulation of T3 formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 577337     DOI: 10.1530/acta.0.0850526

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

Review 1.  [Theory and practice of perioperative trauma-adapted parenteral feeding].

Authors:  M Georgieff
Journal:  Z Ernahrungswiss       Date:  1982-12

2.  Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation.

Authors:  S Adami; M Ferrari; G Galvanini; L Cominacini; F Bruni; M Pelloso; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Variations of thyroid hormones during total fasting in obese and in obese diabetic subjects.

Authors:  M Marugo; M Bagnasco; M Contessini; D Bessarione; F Schenone; D Mignone; D Bernasconi; G Mazzocchi; M Giusti
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

4.  On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.

Authors:  David P Sonne; Asger Lund; Jens Faber; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  Endocr Connect       Date:  2014-10-02       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.